Aidsbeacon - aidsbeacon.com - The AIDS Beacon
General Information:
Latest News:
Beacon NewsFlashes – January 6, 2012 7 Jan 2012 | 05:23 am
Generic Version Of Combivir Is Now Available – The generic version of Combivir (lamivudine/zidovudine), made by generic drug maker Teva Pharmaceuticals, is now available. Teva stated that it began shi...
Beacon NewsFlashes – December 27, 2011 28 Dec 2011 | 08:11 am
HHS Warns Against Three-Month Short-Course Tuberculosis Treatment For People On Antiretroviral Therapy – The Department of Health and Human Services (HHS) has warned that people with HIV who are on an...
Beacon NewsFlashes – December 19, 2011 20 Dec 2011 | 06:30 am
Gilead Applies For Approval For Truvada As An HIV-Prevention Drug – Gilead Sciences has applied for approval from the U.S. Food and Drug Administration (FDA) to market Truvada (emtricitabine/tenofovir...
Beacon NewsFlashes – December 13, 2011 14 Dec 2011 | 08:47 am
Norvir Prescribing Information Updated To Include Risk Of Life-Threatening Skin Condition – The U.S. Food and Drug Administration (FDA) has approved updated prescribing information for Norvir (ritonav...
Beacon NewsFlashes – December 5, 2011 6 Dec 2011 | 06:11 am
President Obama Allocates An Additional $35 Million Toward ADAPs – In a speech on December 1, World AIDS Day, President Obama announced that the federal government will contribute an additional $35 mi...
Beacon NewsFlashes – November 28, 2011 29 Nov 2011 | 08:03 am
People With HIV Are At Increased Risk Of Six Cancers – Results from a recent study indicate that people with HIV are at an increased risk of developing Kaposi’s sarcoma, non-Hodgkin’s lymphoma, Hodgki...
Beacon NewsFlashes – November 21, 2011 22 Nov 2011 | 05:30 am
Foundation For AIDS Research Announces Additional $2.1 Million In Grants Towards AIDS Cure – The Foundation for AIDS Research (amfAR) has announced that it will distribute an additional $2.1 million i...
Beacon NewFlashes – November 14, 2011 15 Nov 2011 | 05:41 am
Merck To Collaborate With The Vaccine And Gene Therapy Institute On HIV Latency Research – U.S. pharmaceutical company Merck has entered into a three-year agreement with the Vaccine and Gene Therapy I...
Beacon NewsFlashes – November 8, 2011 9 Nov 2011 | 08:54 am
Isentress Prescribing Information Updated To Warn Of Severe Rash – The U.S. Food and Drug Administration (FDA) recently announced that the prescribing information for Isentress (raltegravir) has been ...
Estudio clínico en fase 3 demuestra que la pastilla “Quad” contra el VIH es tan eficaz como el Reyataz tomado con la Truvada 2 Nov 2011 | 02:06 am
Los resultados de un estudio clínico en fase 3 aún en curso indican que la pastilla de combinación conocida informalmente como “Quad”, que se toma una vez al día, es tan eficaz como el Reyataz combina...
